Patient Characteristics From a Regional Multicenter Database of Acute Decompensated Heart Failure in Asia Pacific (ADHERE International-Asia Pacific)

详细信息    查看全文

• 作者：John J. Atherton ; PhD ; MBBS ; FRACP ; FCSANZ¹ ; ² ; ^{john_atherton@health.qld.gov.au} ; Christopher S. Hayward ; BMedSc ; MD ; FRACP ; FCSANZ³ ; Wan Azman Wan Ahmad ; MBBS ; MRCP⁴ ; Bernard Kwok ; MBBS ; MMed ; MRCP⁵ ; Jesus Jorge ; MD ; FPCC⁶ ; Adrian F. Hernandez ; MD ; MHS⁷ ; Li Liang ; PhD⁷ ; Robb D. Kociol ; MD⁷ ; Henry Krum ; PhD ; MBBS ; FRACP ; FCSANZ⁸ ; ADHERE International&ndash ; Asia Pacific Scientific Advisory Committee
• 关键词：Heart failure ; registry ; quality indicators
• 刊名：Journal of Cardiac Failure
• 出版年：2012
• 出版时间：January 2012
• 年：2012
• 卷：18
• 期：1
• 页码：82-88
• 全文大小：170 K

文摘

Background

Heart failure (HF) is a leading cause of hospitalization. Although a number of multicenter international HF hospital registries have been published, there are limited data for the Asia Pacific region.

Methods

ADHERE (ie, Acute Decompensated Heart Failure Registry) International-Asia Pacific is an electronic web-based observational database of 10,171 patients hospitalized with a principal diagnosis of HF from 8 Asia-Pacific countries between January 2006 and December 2008.

Results

The median age (67 years) varied by more than 2 decades across the region. Fifty-seven percent of patients were male. Ninety percent of patients were Asian and 8.4 % were white. Dyspnea was the presenting symptom in 95 % , with 80 % having documented rales. During the index hospitalization, left ventricular function was assessed in 50 % , and intravenous therapies included diuretics (85 % ), vasodilators (14 % ), and positive inotropes (15 % ). In-hospital mortality was 4.8 % . Discharge medications included angiotensin-converting enzyme inhibitors and/or angiotensin receptor blockers (63 % ), ¦Â-blockers (41 % ), and aldosterone antagonists (31 % ).

Conclusions

Compared with other multicenter registries, patients hospitalized with acute HF in the Asia Pacific region tend to present with more severe clinical symptoms and signs and are younger, especially in countries at an earlier stage in their epidemiological transition. Echocardiography and disease-modifying medications are used less often, highlighting potential opportunities to improve outcomes.